Cynomolgus CD33L3 Protein, His Tag
- 
									
产品编号
KMP2264
 - 
									
别名
唾液酸结合免疫球蛋白样凝集素-15, Sialic acid-binding Ig-like lectin 15, Siglec-15
 - 
									
规格
- 50ug
 - 100ug
 - 200ug
 
 
| Catalog Number | KMP2264 | 
| Alias | 唾液酸结合免疫球蛋白样凝集素-15, Sialic acid-binding Ig-like lectin 15, Siglec-15 | 
| Size | 50ug, 100ug, 200ug | 
| Product Description | The Cynomolgus CD33L3 Protein(KMP2264) is produced in HEK293 Cells and the target gene encoding Phe20-Thr263 is expressed with a 6His tag at the C-terminus. | 
| Molecular Name | CD33L3 | 
| Product Introduction | CD33L3(Siglec-3L):免疫球蛋白超家族(IgSF)成员,通过跨膜形式参与髓系细胞功能调节。 | 
| Molecular Weight | 27.5 kDa | 
| Expression System | HEK293 Cells | 
| Species | Cynomolgus | 
| Purity | >95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | A0A2K5UY47 | 
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, 150mM Nacl, 0.3% Chaps, 5% Trehalose, pH7.4 | 
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. | 
| Background | Human Siglec-15 is a transmembrane glycoprotein in the Siglec family. Siglecs are type I transmembrane proteins where the NH3+-terminus is in the extracellular space and the COO--terminus is cytosolic. Each Siglec contains an N-terminal V-type immunoglobulin domain(Ig domain) which acts as the binding receptor for sialic acid. These lectins are placed into the group of I-type lectins because the lectin domain is an immunoglobulin fold. All Siglecs are extended from the cell surface by C2-type Ig domains which have no binding activity. Siglecs differ in the number of these C2-type domains. Human Siglec-15 consists of a 244 amino acid(aa) extracellular domain(ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 44 aa cytoplasmic domain. Siglec-15 function is important for osteoclast formation and TRANCE/RANK Ligand signaling in osteoclasts | 
| Endotoxin | <1.0 EU/ug determined by the LAL method | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
可在纯化过程中加入蛋白酶抑制剂、低温操作,优化储存条件(如分装冻存于-80°C),并避免反复冻融。某些情况下,可选用蛋白酶缺陷型宿主菌减少降解风险。
常用SDS-PAGE、Western Blot检测表达,BCA/Bradford法测浓度,HPLC或质谱分析纯度,生物活性实验(如ELISA、酶活检测)验证功能。
							
							
							
							
						
								0